EMA — authorised 21 February 2018
- Marketing authorisation holder: Novo Nordisk A/S
- Status: approved
🇪🇺 Ozempic in European Union
EMA authorised Ozempic on 21 February 2018
Marketing authorisation
Ozempic in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in European Union
Frequently asked questions
Is Ozempic approved in European Union?
Yes. EMA authorised it on 21 February 2018.
Who is the marketing authorisation holder for Ozempic in European Union?
Novo Nordisk A/S holds the EU marketing authorisation.